The UK’s new Cancer Drugs Fund (CDF) puts decisions about the access of several oncology drugs in the hands of the National Institute of Health and Care Excellence (NICE). Do pharma companies and charities have a reason to be so concerned about pricing and access under this new scheme? Read more here. (Source: Phil Taylor, PMLiVE, 8/1/16)
You are here: / / Will the New CDF Bring Clearer, Faster Decision Making?